CN110577989A - probe, gene chip and kit for detecting genes related to sudden exercise death - Google Patents

probe, gene chip and kit for detecting genes related to sudden exercise death Download PDF

Info

Publication number
CN110577989A
CN110577989A CN201910831612.8A CN201910831612A CN110577989A CN 110577989 A CN110577989 A CN 110577989A CN 201910831612 A CN201910831612 A CN 201910831612A CN 110577989 A CN110577989 A CN 110577989A
Authority
CN
China
Prior art keywords
probe
gene chip
gene
death
kit
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201910831612.8A
Other languages
Chinese (zh)
Other versions
CN110577989B (en
Inventor
王丽玲
谢红光
肖杰
杭建
宋家武
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zhuhai Sinochips Biotechnology Co ltd
Original Assignee
Selec Biotechnology Nanjing Co Ltd
Zhuhai Sinochips Biotechnology Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Selec Biotechnology Nanjing Co Ltd, Zhuhai Sinochips Biotechnology Co Ltd filed Critical Selec Biotechnology Nanjing Co Ltd
Priority to CN201910831612.8A priority Critical patent/CN110577989B/en
Publication of CN110577989A publication Critical patent/CN110577989A/en
Application granted granted Critical
Publication of CN110577989B publication Critical patent/CN110577989B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813Hybridisation assays
    • C12Q1/6834Enzymatic or biochemical coupling of nucleic acids to a solid phase
    • C12Q1/6837Enzymatic or biochemical coupling of nucleic acids to a solid phase using probe arrays or probe chips
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

The invention belongs to the technical field of biological detection, and discloses a probe, a gene chip and a kit for detecting genes related to exercise sudden death. The probe comprises a probe I736I probe, an I736T probe, a P731P probe, a P731S probe, a R723R probe, a R723G probe, a R663R probe, a R663H probe, a Y842Y probe, a Y842X probe, a R190R probe, a R190W probe, a W305W probe, a W305L probe, a R2401R probe and a R2401H probe. The gene chip contains the probe. The kit comprises the probe and a gene chip. The invention combines the gene chip method through the selection of the specific probe and the primer, and has the advantages of good specificity, high accuracy, rapidness and convenience; the visible light optical amplification of the gene chip can achieve higher signal resolution; meanwhile, one-time multi-site determination of the gene related to the sudden exercise death is realized, and the detection time and cost are reduced; the detection result can be directly read by photographing or naked eyes, and is simple and convenient.

Description

Probe, gene chip and kit for detecting genes related to sudden exercise death
Technical Field
the invention belongs to the technical field of biological detection, and particularly relates to a probe, a gene chip and a kit for detecting genes related to exercise sudden death.
background
Violent exercise or emotional overstimulation can induce syncope or sudden death. Of these, Hypertrophic Cardiomyopathy (HCM) and the QT interval (total time course of ventricular depolarization and repolarization processes) prolongation syndrome (LQTS) are the major causes of motion-related syncope or sudden death, and these disorders are genetically related.
according to the European and American study, HCM is the most common cause of sudden death among young people or athletes under 35 years old, accounting for about 1/500. Up to 900 mutations have been found or identified in HCM-associated genes distributed over 13 cardiac sarcomere-encoding genes, the major genes being MYH7 (encoding β -myosin heavy chain), MYBPC3 (encoding myosin-binding protein C), and TNNT2 (encoding cardiac troponin T). For HCM, clinical or forensic reports are individual case or family reports, and at present, no single gene or single mutation can specifically and accurately predict the clinical phenotype and the risk degree of the carrier, and some individual case cases even exist in combination of multiple genes and multiple mutations. But double mutations are more dangerous than single mutations; the hazard of the MYH7 mutation is significantly greater than the hazard of the MYBPC3 mutation. Now in connection with the report on the chinese population retrieved on PubMed, suggested sites for detection are as follows:
MYH7 gene has been reported to be associated with syncope or sudden death gene mutations: N391T, I736T, P731S, R723G, R719Q, R663H and the like.
MYBPC3 is a crude myofilament-binding protein with a relative molecular mass of approximately 150000, HCM caused by MYBPC3 mutations account for 20% -25% of cases, and MYBPC3 gene has been reported to be associated with mutations in syncope or sudden death: Y842X, and the like.
in LQTS, multiple mutations in multiple genes can lead to LQTS. Wherein, LQT1 (type 1 long QT syndrome) affects about 50% of LQT gene mutation carriers, KCNQ1 is a pathogenic gene thereof and can cause syncope, sudden death or drowning of male teenagers in the process of exercise, particularly swimming; LQT2 (type 2 Long QT syndrome) is the most common LQT subtype among Chinese people, affects about 40% of carriers, has a pathogenic gene KCNH2, mainly affects women, and shows that syncope or sudden death can be induced at night under loud noise; LQT3 (type 3 long QT syndrome) affects about 10% of carriers, the causative gene is SCN5A, which is commonly found in adult males and manifests as syncope or sudden death in sleep. It can be seen that most of the genes causing syncope or sudden death in rest or sleep are LQT2 and LQT3, so both of them are not associated much with exercise-induced syncope or sudden death. Now in connection with the report on the chinese population retrieved on PubMed, suggested sites for detection are as follows:
Mutations in KCNQ1 that can induce syncope or sudden death are: R190W, R380S, W305L, and the like.
catecholamine-derived (or sympathetic-derived) multiple ventricular tachycardia (CPVT) is also associated with the occurrence of syncope or sudden death. Mutations in the RyR2 receptor (cardiac calcium ion release channel) gene (or CPVT-1-type associated gene) are associated with more than 50% of CPTV cases. The disease begins in adolescent period, and sudden syncope recurrent attacks, consciousness loss and even sudden cardiac death appear under stress conditions such as exercise or emotional agitation. The reported SNP sites of the RyR2 gene mainly comprise R2401H.
at present, although partial research on sudden cardiac death mutation gene detection is carried out, more sudden death-related gene detection is not carried out. Therefore, it is necessary to provide a more excellent probe, gene chip and kit for detecting a gene related to sudden exercise death.
disclosure of Invention
aiming at the defects of the prior art, the invention provides a probe, a gene chip and a kit for detecting a gene related to sudden exercise death. The invention has the advantages of high specificity, good accuracy and capability of rapidly detecting multiple sites at one time.
A probe for detecting a gene associated with sudden exercise death, the probe having the sequence:
I736I probe: GTTCATTGATAGCAGGA, respectively;
I736T probe: GTTCACTGATAGCAGGA, respectively;
P731P probe: AGCGGCCATCCCTGAGGG, respectively;
P731S probe: AGCGGCCATCTCTGAGGG, respectively;
R723R probe: CCTCAGGTATCGCATCCT, respectively;
R723G probe: CCTCAGGTATGGCATCCT, respectively;
R663R probe: CAACTTGCGCTCCACCCA, respectively;
R663H probe: CAACTTGCACTCCACCCA, respectively;
Y842Y probe: GTGTACGAGATGCGCGTC, respectively;
Y842X probe: GGTGTAGGAGATGCGCGT, respectively;
R190R probe: CTCTGGGGGCGGCTGCGC, respectively;
R190W probe: CTCTGGGGGTGGCTGCGC, respectively;
W305W probe: CGCTGTGGTGGGGGGTGG, respectively;
W305L probe: CGCTGTGGTTGGGGGTGG, respectively;
R2401R probe: CTCTTGGGACGCTGTGCTC, respectively;
R2401H probe: CTCTTGGGACACTGTGCTC are provided.
a gene chip for detecting a gene related to sudden exercise death comprises the probe.
A preparation method of a gene chip for detecting a gene related to sudden exercise death comprises the following steps:
(1) Coating a film on a substrate to obtain a biosensor;
(2) Covering a coating on the biosensor, treating the biosensor with 6-hydrazino nicotinic acid succinimide ester hydrochloride, and washing the biosensor with water;
(3) And (3) spotting the modified probe on a biosensor to prepare the gene chip.
Preferably, the substrate in the step (1) is a silicon wafer (Si) with a thickness of 2.5mm and a diameter of 20-25 cm.
Preferably, the film coating in the step (1) is to coat a silicon nitride film with the thickness of 45-50nm and a TSPS (T structure polydimethylsiloxane) film with the thickness of 12-15nm on a silicon wafer.
preferably, the coating in the step (2) is a polyphenylalanine-lysine coating, and the thickness of the polyphenylalanine-lysine coating is 15 nm; the concentration of the 6-hydrazino nicotinic acid succinimide ester hydrochloride is 1-10 mu mol/L, and the treatment time of the 6-hydrazino nicotinic acid succinimide ester hydrochloride is 15-25 min.
preferably, in the step (3), one end of the probe is modified by aldehyde group or amino group.
A kit for detecting genes related to exercise-induced sudden death comprises a gene chip, a PCR reaction system, a hybridization buffer solution, a washing solution, a BW reaction solution (horseradish peroxidase + sodium citrate buffer solution) and a TMB (3,3',5,5' -tetramethylbenzidine) color development solution.
Preferably, the PCR reaction system comprises the following components: 5 × Buffer, dUTP mix, F-primer, R-primer, Hot taq, UNG enzyme (uracil DNA glycosylase) and dd H2o (double distilled water).
The UNG enzyme is added into a PCR reaction system, so that the pollution of amplification products can be removed, and false positive results are reduced.
Preferably, the sequence of the F-primer is:
663-F:5'-TGCATCTCTTTCTGGCATT-3';
723/731/736-F:5'-TCTATGGGCAGAGCAGATCAC-3';
842-F:5'-TGCGGCTGAACTTCGACC-3';
190-F:5'-GAGTACGTGGTCCGCCT-3';
305-F:5'-CATCTTCTCCTCGTACTTTGTG-3';
2401-F:5'-GGAACGCGATGACC-3'。
Preferably, the sequence of the R-primer is:
663-R:5'-CCTCACCTGGAGACTTTG-3';
723/731/736-R:5'-ACTGGTTGTGATCAATGTCCAG-3';
842-R:5'-AGGCTCACCGATAGGCAT-3';
190-R:5'-TCCACAGGGCAGGCATGACTC-3';
305-R:5'-CACCAGTGCCCAGATGTC-3';
2401-R:5'-ATGCTGTTATGCTCTTTGAC-3'。
Preferably, the hybridization buffer comprises 0.3mol/L trisodium citrate, 3mol/L sodium chloride, 0.3mol/L sodium dodecyl sulfate and Triton X-1000.1% aqueous solution.
Preferably, the washing solution is a 0.1 XSSC solution.
A detection method of a gene related to sudden exercise death adopts the kit for detection, and comprises the following steps:
(1) Adding the substance to be detected into a PCR reaction system for amplification to obtain a PCR amplification product;
(2) Adding PCR amplification product and hybridization buffer solution on the gene chip for reaction;
(3) washing the gene chip with 0.1 XSSC solution, and drying in the air after washing;
(4) taking BW reaction liquid to react on a gene chip at room temperature;
(5) adding TMB color developing solution for color development, washing the gene chip with 0.1 XSSC solution before and after adding the TMB color developing solution, air drying, and taking pictures or reading the detection result by naked eyes.
the sample contains DNA fragments.
the detection of the kit and the object to be detected is hybridization reaction, and when the object to be detected contains SNP (single nucleotide polymorphism) sites of a target gene which can be specifically combined with the probe, the gene chip area corresponding to the probe is blue.
Preferably, the conditions for amplification in step (1) are: reacting at 95 ℃ for 10 min; denaturation at 94 ℃ for 30s, renaturation at 56 ℃ for 30s, and extension at 72 ℃ for 30s, and repeating 40 cycles; extension at 72 ℃ for 5 min.
preferably, the addition amount of the PCR amplification product in the step (2) is 10. mu.L, and the hybridization buffer is 100. mu.L; the reaction conditions were: reacting for 30-60min at 50-60 ℃.
Preferably, the temperature of the 0.1 XSSC solution in step (3) is 50 ℃ and the washing time is 1 min.
preferably, the amount of BW reaction solution added in step (4) is 100. mu.L, and the reaction time is 10 min.
preferably, the addition amount of the TMB color developing solution in the step (5) is 100 mu L, and the reaction time is 5 min; the mixture was washed 3 times with 0.1 XSSC solution before and after addition of TMB developing solution, each for 1 min.
compared with the prior art, the invention has the following beneficial effects:
(1) By adopting a gene chip method, the one-time multi-site determination of the genes related to the sudden exercise death is realized, and the detection time and the detection cost are reduced;
(2) the invention combines the gene chip method through the selection of the specific probe and the primer, and has the advantages of good specificity, high accuracy, rapidness and convenience;
(3) the visible light optical amplification of the gene chip can achieve higher signal resolution;
(4) The detection result can be directly read by photographing or naked eyes, and is simple and convenient.
drawings
FIG. 1 is a diagram showing the results of detecting mixed plasmids containing plasmids 1, 3, 5, 7, 9, 11, 13 and 15 using the gene chip and the kit prepared in examples 1-2 of the present invention;
FIG. 2 shows the results of detecting mixed plasmids containing plasmids 2, 4, 6, 8, 10, 12, 14 and 16 using the gene chip and the kit prepared in example 1-2 of the present invention;
FIG. 3 shows the results of testing the plasmid mixture containing plasmids 1-16 using the gene chip and the kit prepared in examples 1-2 of the present invention.
Detailed Description
in order to make the technical solutions of the present invention more apparent to those skilled in the art, the following examples are given for illustration. It should be noted that the following examples are not intended to limit the scope of the claimed invention.
example 1
A probe for detecting a gene related to sudden exercise death, which has the sequence as follows:
I736I probe: GTTCATTGATAGCAGGA, respectively;
I736T probe: GTTCACTGATAGCAGGA, respectively;
P731P probe: AGCGGCCATCCCTGAGGG, respectively;
P731S probe: AGCGGCCATCTCTGAGGG, respectively;
R723R probe: CCTCAGGTATCGCATCCT, respectively;
R723G probe: CCTCAGGTATGGCATCCT, respectively;
R663R probe: CAACTTGCGCTCCACCCA, respectively;
R663H probe: CAACTTGCACTCCACCCA, respectively;
Y842Y probe: GTGTACGAGATGCGCGTC, respectively;
Y842X probe: GGTGTAGGAGATGCGCGT, respectively;
R190R probe: CTCTGGGGGCGGCTGCGC, respectively;
R190W probe: CTCTGGGGGTGGCTGCGC, respectively;
W305W probe: CGCTGTGGTGGGGGGTGG, respectively;
W305L probe: CGCTGTGGTTGGGGGTGG, respectively;
R2401R probe: CTCTTGGGACGCTGTGCTC, respectively;
R2401H probe: CTCTTGGGACACTGTGCTC are provided.
a gene chip containing the probe for detecting the gene related to the sudden exercise death comprises the following steps:
A silicon nitride film with the thickness of 47.5nm and a TSPS film with the thickness of 13.5nm are coated on a silicon wafer (Si) with the thickness of about 2.5mm and the diameter of 20cm by a rotary vacuum coating machine and a vacuum vapor deposition method to prepare a corresponding biosensor, a polyphenylalanine-lysine coating with the thickness of 15nm is covered on the biosensor, finally, the biosensor is treated by 10 mu mol/L6-hydrazino nicotinic acid succinimide ester hydrochloride for 20 minutes, and the chip is cleaned by clear water. Modifying the 5' end of the probe for detecting the genes related to the sudden exercise death by aldehyde group, spotting the probe on a processed chip, and reacting at room temperature to prepare the gene chip containing the probe.
Each probe was placed in three parallel arrays on the chip, so the arrangement of the probes on the chip is shown in Table 1:
table 1: gene chip probe sample application arrangement
The quality control probe is PolyA, and the sequence is AAAAAAAAAAAAAAAAAA.
The quality control probe not only plays a role in positioning but also plays a role in quality control on the gene chip. When the detection result does not develop color at the point of sample application of the quality control probe, the gene chip is proved to be invalid.
Example 2
a kit for detecting folate gene polymorphism, which comprises the gene chip, PCR reaction system, hybridization buffer, washing solution, BW reaction solution and TMB color solution of example 1.
Wherein the composition of the PCR reaction system is shown in Table 2:
table 2: PCR reaction System composition
Wherein the sequence of the F-primer in the PCR reaction system is as follows:
663-F:5'-TGCATCTCTTTCTGGCATT-3';
723/731/736-F:5'-TCTATGGGCAGAGCAGATCAC-3';
842-F:5'-TGCGGCTGAACTTCGACC-3';
190-F:5'-GAGTACGTGGTCCGCCT-3';
305-F:5'-CATCTTCTCCTCGTACTTTGTG-3';
2401-F:5'-GGAACGCGATGACC-3'。
wherein the sequence of the R-primer in the PCR reaction system is as follows:
663-R:5'-CCTCACCTGGAGACTTTG-3';
723/731/736-R:5'-ACTGGTTGTGATCAATGTCCAG-3';
842-R:5'-AGGCTCACCGATAGGCAT-3';
190-R:5'-TCCACAGGGCAGGCATGACTC-3';
305-R:5'-CACCAGTGCCCAGATGTC-3';
2401-R:5'-ATGCTGTTATGCTCTTTGAC-3'。
wherein the hybridization buffer comprises 0.3mol/L trisodium citrate, 3mol/L sodium chloride, 0.3mol/L sodium dodecyl sulfate and Triton X-1000.1% aqueous solution.
Wherein the washing solution is a 0.1 XSSC solution.
Wherein the Hot-Taq enzyme, dUTP and UNG enzyme are purchased from Shenzhen Fenpeng biological member GmbH.
wherein the primer and the probe are designed by self and synthesized by Shanghai biological engineering Co.
Example 3
the gene chip and the kit prepared in example 1-2 were used for detection, and the object to be detected was a plasmid containing the SNP site of the target gene, and the types of the plasmid are shown in Table 3:
Table 3: plasmid type
plasmids Containing the target gene SNP site
Plasmid 1 MYH7 R663R
plasmid 2 MYH7 R663H
plasmid 3 MYH7 R723R
Plasmid 4 MYH7 R723G
Plasmid 5 MYH7 P731P
Plasmid 6 MYH7 P731S
plasmid 7 MYH7 I736I
Plasmid 8 MYH7 I736T
Plasmid 9 MYBPC3 Y842Y
Plasmid 10 MYBPC3 Y842X
plasmid 11 KCNQ1 R190R
plasmid 12 KCNQ1 R190W
Plasmid 13 KCNQ1 W305W
Plasmid 14 KCNQ1 W305L
plasmid 15 RyR2 R2401R
plasmid 16 RyR2 R2401H
the above plasmids are synthesized and provided by Shanghai Bioengineering Co., Ltd.
Plasmids 1, 3, 5, 7, 9, 11, 13 and 15 were mixed to obtain a mixed plasmid, and the mixed plasmid was dissolved in 1mL of TE buffer so that the concentration of the plasmid was 2. mu.g/mL, i.e., 2000 ng/mL. And adding 5 mu L of plasmid solution serving as a substance to be detected into a PCR reaction system to ensure that the total reaction volume is 50 mu L, and preparing a PCR reaction mixed solution.
Putting the PCR reaction mixed solution into a PCR instrument for PCR amplification, wherein the conditions of the PCR amplification are as follows:
reacting at 95 ℃ for 10 min; denaturation at 94 ℃ for 30s, renaturation at 56 ℃ for 30s, and extension at 72 ℃ for 30s, and repeating 40 cycles; extension at 72 ℃ for 5 min.
After the amplification is finished, heating the PCR amplification product for 3 minutes at 95 ℃, and quickly placing the PCR amplification product on ice;
Taking 10 mu L of PCR amplification product to the prepared chip;
100 mu L of hybridization buffer solution is taken to be arranged on a chip and reacted for 60 minutes at 55 ℃;
washing the chip in 0.1 XSSC solution at 50 deg.C for 1min, and air drying the chip surface;
Taking 100 mu L of BW reaction solution on a chip, and reacting for 10 minutes at room temperature;
washing the chip with 0.1 XSSC solution for 3 times, each time for 1 minute, and air-drying the surface of the chip;
Taking 100 mu L of TMB color developing solution on the surface of the chip, and reacting for 5 minutes;
the chip was washed 3 times with 0.1 XSSC solution for 1 minute each time, the chip surface was air dried, and the results were read by photographing or by naked eye.
As shown in FIG. 1, the detection results were that the I736I probe, P731P probe, R723R probe, R663R probe, Y842Y probe, R190R probe, W305W probe and R2401R probe all showed blue color at the spot location of the gene chip (zones 1-8, respectively), and the spot location of the quality control probe (zone A) also showed blue color. It was confirmed that the gene chip and the kit prepared in example 1-2 can accurately detect the R663R, R723R, P731P, I736I, Y842Y, R190R, W305W, and R2401R sites. The color development at the probe proves that the substance to be detected contains the SNP sites specifically bound with the probe, for example, parallel sites in the regions 3 and 5 have light color development but still have color development, and the light color development does not influence the detection result.
example 4
example 4 is substantially the same as example 3 except that the test substance used is a mixed plasmid containing plasmids 2, 4, 6, 8, 10, 12, 14, and 16.
the test substance was detected using the gene chip and the kit prepared in example 1-2.
As shown in FIG. 2, the detection results were confirmed that the I736T probe, P731S probe, R723G probe, R663H probe, Y842X probe, R190W probe, W305L probe and R2401H probe all showed blue color at the spot of the gene chip (regions 9-16, respectively), and the spot of the quality control probe (region A) also showed blue color, and that the gene chip and the kit prepared in example 1-2 could accurately detect the I736T, P731S, R723G, R663H, Y842X, R190W, W305L and R2401H sites.
example 5
example 5 is substantially the same as example 3 except that the specimen used is a mixed plasmid containing plasmids 1 to 16.
the test substance was detected using the gene chip and the kit prepared in example 1-2.
as shown in FIG. 3, the detection results were confirmed to be excellent in specificity even when 16 types of plasmids were mixed by using the gene chip and the kit prepared in examples 1 to 2, and accurate detection results were obtained in the same manner as the I736I probe, the P731P probe, the R723R probe, the R663R probe, the Y842Y probe, the R190R probe, the W305W probe, the R2401R probe, the I736T probe, the P731S probe, the R723G probe, the R663H probe, the Y842X probe, the R190W probe, the W305L probe, and the R2401H probe all showed blue colors at the spot location (regions 1 to 16, respectively) on the gene chip.

Claims (10)

1. a probe for detecting a sudden kinetic death-related gene, wherein the sequence of the probe is:
I736I probe: GTTCATTGATAGCAGGA, respectively;
I736T probe: GTTCACTGATAGCAGGA, respectively;
P731P probe: AGCGGCCATCCCTGAGGG, respectively;
P731S probe: AGCGGCCATCTCTGAGGG, respectively;
R723R probe: CCTCAGGTATCGCATCCT, respectively;
R723G probe: CCTCAGGTATGGCATCCT, respectively;
R663R probe: CAACTTGCGCTCCACCCA, respectively;
R663H probe: CAACTTGCACTCCACCCA, respectively;
Y842Y probe: GTGTACGAGATGCGCGTC, respectively;
Y842X probe: GGTGTAGGAGATGCGCGT, respectively;
R190R probe: CTCTGGGGGCGGCTGCGC, respectively;
R190W probe: CTCTGGGGGTGGCTGCGC, respectively;
W305W probe: CGCTGTGGTGGGGGGTGG, respectively;
W305L probe: CGCTGTGGTTGGGGGTGG, respectively;
R2401R probe: CTCTTGGGACGCTGTGCTC, respectively;
R2401H probe: CTCTTGGGACACTGTGCTC are provided.
2. a gene chip for detecting a gene associated with sudden exercise death, which comprises the probe of claim 1.
3. A method for preparing the gene chip of claim 2, comprising the steps of:
(1) coating a film on a substrate to obtain a biosensor;
(2) covering a coating on the biosensor, treating the biosensor with 6-hydrazino nicotinic acid succinimide ester hydrochloride, and washing the biosensor with water;
(3) And (3) spotting the modified probe on a biosensor to prepare the gene chip.
4. The preparation method according to claim 3, wherein one end of the probe is modified with aldehyde or amino in the step (3).
5. a kit for detecting a gene associated with sudden exercise death, comprising the gene chip of claim 2, a PCR reaction system, a hybridization buffer, a washing solution, a BW reaction solution and a TMB color developing solution.
6. The kit of claim 5, wherein the PCR reaction system comprises the following components: 5 XBuffer, dUTP mix, F-primer, R-primer, Hot taq, UNG enzyme and dd H2O.
7. The kit of claim 6, wherein the F-primer has the sequence:
663-F:5'-TGCATCTCTTTCTGGCATT-3';
723/731/736-F:5'-TCTATGGGCAGAGCAGATCAC-3';
842-F:5'-TGCGGCTGAACTTCGACC-3';
190-F:5'-GAGTACGTGGTCCGCCT-3';
305-F:5'-CATCTTCTCCTCGTACTTTGTG-3';
2401-F:5'-GGAACGCGATGACC-3'。
8. the kit according to claim 6, wherein the sequence of the R-primer is:
663-R:5'-CCTCACCTGGAGACTTTG-3';
723/731/736-R:5'-ACTGGTTGTGATCAATGTCCAG-3';
842-R:5'-AGGCTCACCGATAGGCAT-3';
190-R:5'-TCCACAGGGCAGGCATGACTC-3';
305-R:5'-CACCAGTGCCCAGATGTC-3';
2401-R:5'-ATGCTGTTATGCTCTTTGAC-3'。
9. The kit of claim 5, wherein the hybridization buffer comprises 0.3mol/L trisodium citrate, 3mol/L sodium chloride, 0.3mol/L sodium dodecyl sulfate, and Triton X-1000.1% aqueous solution.
10. a method for detecting a sudden exercise death-related gene, which comprises the steps of using the kit according to any one of claims 5 to 9 for detection, comprising:
(1) Adding the substance to be detected into a PCR reaction system for amplification to obtain a PCR amplification product;
(2) Adding PCR amplification product and hybridization buffer solution on the gene chip for reaction;
(3) Washing the gene chip with 0.1 XSSC solution, and drying in the air after washing;
(4) taking BW reaction liquid to react on a gene chip at room temperature;
(5) adding TMB color developing solution for color development, washing the gene chip with 0.1 XSSC solution before and after adding the TMB color developing solution, air drying, and taking pictures or reading the detection result by naked eyes.
CN201910831612.8A 2019-09-04 2019-09-04 Probe, gene chip and kit for detecting genes related to sudden exercise death Active CN110577989B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201910831612.8A CN110577989B (en) 2019-09-04 2019-09-04 Probe, gene chip and kit for detecting genes related to sudden exercise death

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201910831612.8A CN110577989B (en) 2019-09-04 2019-09-04 Probe, gene chip and kit for detecting genes related to sudden exercise death

Publications (2)

Publication Number Publication Date
CN110577989A true CN110577989A (en) 2019-12-17
CN110577989B CN110577989B (en) 2020-11-10

Family

ID=68812484

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201910831612.8A Active CN110577989B (en) 2019-09-04 2019-09-04 Probe, gene chip and kit for detecting genes related to sudden exercise death

Country Status (1)

Country Link
CN (1) CN110577989B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112080562A (en) * 2020-08-18 2020-12-15 珠海赛乐奇生物技术股份有限公司 Gene chip and kit for detecting hypertension drug treatment related gene

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006131528A2 (en) * 2005-06-07 2006-12-14 Fondazione Salvatore Maugeri Clinica Del Lavoro E Della Riabilitazione I.R.C.C.S. Mutations associated with the long qt syndrome and diagnostic use thereof
CN109652531A (en) * 2019-01-11 2019-04-19 中国人民解放军总医院 It is a kind of to cause a disease the/probe groups of tumor susceptibility gene for detecting genetic cardiomyopathies/arrhythmia cordis

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006131528A2 (en) * 2005-06-07 2006-12-14 Fondazione Salvatore Maugeri Clinica Del Lavoro E Della Riabilitazione I.R.C.C.S. Mutations associated with the long qt syndrome and diagnostic use thereof
CN109652531A (en) * 2019-01-11 2019-04-19 中国人民解放军总医院 It is a kind of to cause a disease the/probe groups of tumor susceptibility gene for detecting genetic cardiomyopathies/arrhythmia cordis

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
F.CANNA等: "Phenotype-driven molecular autopsy for sudden cardiac death", 《CLIN GENET》 *
MAK, CHLOE M.等: "Genetic Basis of Channelopathies and Cardiomyopathies in Hong Kong Chinese Patients: A 10-year Regional Laboratory Experience", 《HONG KONG MEDICAL JOURNAL》 *
叶文虎等: "《现代临床遗传学》", 30 November 1996, 安徽科学技术出版社 *
李远华: "《普通高等教育"十三五"规划教材 茶学综合实验》", 30 June 2018, 中国轻工业出版社 *
王洪奇等: "《影响21世纪的科学技术新成果》", 30 November 2010, 中国时代经济出版社 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112080562A (en) * 2020-08-18 2020-12-15 珠海赛乐奇生物技术股份有限公司 Gene chip and kit for detecting hypertension drug treatment related gene

Also Published As

Publication number Publication date
CN110577989B (en) 2020-11-10

Similar Documents

Publication Publication Date Title
JP6766037B2 (en) Use of the FGFR Mutant Panel in Identifying Cancer Patients Responsive to Treatment with FGFR Inhibitors
US20170198356A1 (en) Tert fusions
JP4276691B2 (en) Male infertility-related gene protamine-2 mutation and diagnostic method for male infertility
US20140005070A1 (en) Markers associated with cyclin-dependent kinase inhibitors
JP2002529069A (en) Chlamydia pneumoniae genome sequence
JP2001069997A (en) Hiv probe used for solution phase sandwich hybridization assay
Xuan et al. Detection of clarithromycin-resistant Helicobacter pylori in clinical specimens by molecular methods: A review
JP2008534009A (en) Multiple SNP for diagnosing colorectal cancer, microarray and kit including the same, and method for diagnosing colorectal cancer using the same
CN110577989B (en) Probe, gene chip and kit for detecting genes related to sudden exercise death
JP4926966B2 (en) Dopaminergic neuron proliferative progenitor cell marker Msx1 / 2
KR101634958B1 (en) probes, kits and methods for detecting mutation of filaggrin gene
KR102018369B1 (en) Mutant Genes as Diagnosis Marker for Amyotrophic Lateral Sclerosis and Diagnosis Method Using the Same
JP2006510371A (en) Methods for capturing, detecting and quantifying RNA: DNA hybrids and modified RNase H useful therein
US20210371935A1 (en) Identification of pde3 modulator responsive cancers
JPH1023890A (en) Polyclonal antibody, monoclonal antibody and hybridoma capable of producing the monoclonal antibody
CN108642169B (en) Method for detecting drug-resistant genes of ten trimethoprim drugs and kit used by same
JP4836168B2 (en) Primer set for detecting single nucleotide polymorphism of N-acetyltransferase 2 gene
KR20180100812A (en) Atopic Dermatitis PTGR2 Gene Specifically Expressed in Intestinal Epithelial Cell
WO2015194524A1 (en) B-precursor acute lymphoblastic leukemia novel chimeric gene
US8293474B2 (en) Oligonucleotides and use thereof for determining deletion in HBV Pre-S region
JP2004511208A5 (en)
CN112029905B (en) Gene chip and kit for detecting TORCH pathogen
JP2013051909A (en) Health checkup method of fish by multiplex rt-pcr using cytokine gene
JP4462923B2 (en) Infant severe myoclonic epilepsy-related gene mutation and infant severe myoclonic epilepsy diagnosis method
JP2001502536A (en) Probes, methods and kits for detection and typing of Helicobacter pylori nucleic acids in biological samples

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
TR01 Transfer of patent right
TR01 Transfer of patent right

Effective date of registration: 20221213

Address after: 2101, Floor 1, Comprehensive Office Building and Laboratory Building, No. 24, Jinfeng West Road, Tangjiawan Town, High tech Zone, Zhuhai City, Guangdong Province, 519000

Patentee after: ZHUHAI SINOCHIPS BIOTECHNOLOGY Co.,Ltd.

Address before: 519085 floor 5, building 6, No. 24, Jinfeng West Road, Tangjiawan Town, Zhuhai City, Guangdong Province

Patentee before: ZHUHAI SINOCHIPS BIOTECHNOLOGY Co.,Ltd.

Patentee before: Selec Biotechnology (Nanjing) Co.,Ltd.